Mount Sinai secures $6.2 million grant to expand the Cohen Center for Recovery From Complex Chronic Illnesses

Mount Sinai’s Department of Rehabilitation and Human Performance has announced a $6.2 million grant from the Steven & Alexandra Cohen Foundation.

Comparing the cost-effectiveness of SGLT2i versus mineralocorticoid antagonists

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are approved for heart failure with reduced ejection fraction

June 19, 2023

Boehringer plans to again increase R&D spending; Valneva, Pfizer to advance Lyme vaccine candidate

Plus, news about OPKO, HealthCare Royalty, Inventiva, Exscientia and GT Apeiron: Boehringer Ingelheim ups its R&D budget: Back in April, the company said it …

July 19, 2024

2023 Women in Biopharma R&D; Biotech hopeful for rebound even as new wave of layoffs hit; Novartis’ siRNA buyout; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit

July 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.